相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The efficacy and safety of roxadustat treatment for anemia in patients with kidney disease: a meta-analysis and systematic review
Suhui Qie et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2021)
Roxadustat for CKD-related Anemia in Non-dialysis Patients
Daniel W. Coyne et al.
KIDNEY INTERNATIONAL REPORTS (2021)
Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study
Steven Fishbane et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Effectiveness and safety of roxadustat in the treatment of anemia of kidney disease: a systematic review and meta-analysis
Hui Wang et al.
ANNALS OF PALLIATIVE MEDICINE (2021)
Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis
Li Zhang et al.
Aging-US (2021)
The multifaceted role of iron in renal health and disease
Rachel P. L. van Swelm et al.
NATURE REVIEWS NEPHROLOGY (2020)
The efficacy and economic evaluation of roxadustat treatment for anemia in patients with kidney disease not receiving dialysis
Zhanhong Hu et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2020)
Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta-analysis
Junduo Liu et al.
PHARMACOLOGICAL RESEARCH (2020)
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
Tadao Akizawa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naive Chronic Kidney Disease Patients Not on Dialysis
Tadao Akizawa et al.
NEPHRON (2020)
Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
Tadao Akizawa et al.
ADVANCES IN THERAPY (2019)
Roxadustat and Anemia of Chronic Kidney Disease
Joshua Kaplan
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
N. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis
N. Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A new approach to treating renal anaemia
Patrick H. Maxwell
NATURE REVIEWS NEPHROLOGY (2019)
Balanced crystalloids versus normal saline for fluid resuscitation in critically ill patients: A systematic review and meta-analysis with trial sequential analysis
Chao Liu et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2019)
Effectiveness of hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis
Linpei Jia et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
Joshua M. Kaplan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease
Sho Hasegawa et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2018)
Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease
Mai Sugahara et al.
KIDNEY INTERNATIONAL (2017)
Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China
Nan Chen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6-to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
Robert Provenzano et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia
Elke Marsch et al.
EUROPEAN HEART JOURNAL (2016)
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
Chao Liu et al.
CRITICAL CARE (2016)
Anaemia in kidney disease: harnessing hypoxia responses for therapy
Mark J. Koury et al.
NATURE REVIEWS NEPHROLOGY (2015)
Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
Anatole Besarab et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
Ioannis Koulouridis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Kidney Disease Improving Global Outcomes (Kdigo) Guidelines on Anaemia Management in Chronic Kidney Disease: A European Renal Best Practice (Erbp) Position Statement
Francesco Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Hepcidin is a Potential Regulator of Iron Status in Chronic Kidney Disease
Ken Tsuchiya et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2013)
Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
Tineke W. H. Meijer et al.
CLINICAL CANCER RESEARCH (2012)
Hepcidin: clinical utility as a diagnostic tool and therapeutic target
Daniel W. Coyne
KIDNEY INTERNATIONAL (2011)
Intravenous Iron Versus Erythropoiesis-Stimulating Agents: Friends or Foes in Treating Chronic Kidney Disease Anemia?
Kamyar Kalantar-Zadeh et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses
Jesper Brok et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Direct regulation of TWIST by HIF-1α promotes metastasis
Muh-Hwa Yang et al.
NATURE CELL BIOLOGY (2008)
Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl-coenzyme a reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of Insigs
Andrew D. Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
分享论文
